Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials

INTRODUCTION: Dual antiplatelet therapy (DAPT) including prasugrel or ticagrelor is recommended in patients with acute coronary syndromes (ACS) treated with coronary intervention (PCI). Acknowledging the importance of bleeding, multiple trials tested abatement schemes including uniform or guided de-...

Descripción completa

Detalles Bibliográficos
Autores principales: El Alaoui El Abdallaoui, Oumaima, Tornyos, Dániel, Lukács, Réka, Komócsi, András
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877531/
https://www.ncbi.nlm.nih.gov/pubmed/36712280
http://dx.doi.org/10.3389/fcvm.2022.1008914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877531/
https://www.ncbi.nlm.nih.gov/pubmed/36712280
http://dx.doi.org/10.3389/fcvm.2022.1008914

Ejemplares similares